BCR and myeloid neoplasm: We identified upregulation of Dnmt1 as a consequence of BCR-ABLp210, and we show that HSPC-restricted expression of Dnmt1 in transgenic mice is sufficient to phenocopy the BCR-ABLp210-associated DNA methylation changes and induce myeloid malignancies.